Authors: Begg, AC Haustermans, K Hart, AAM Dische, S Saunders, M Zackrisson, B Gustaffson, H Coucke, P Paschoud, N Hoyer, M Overgaard, J Antognoni, P Richetti, A Bourhis, J Bartelink, H Horiot, JC Corvo, R Giaretti, W Awwad, H Shouman, T Jouffroy, T Maciorowski, Z Dobrowsky, W Struikmans, H Rutgers, D Wilson, GD

Citation: Ac. Begg et al., The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis, RADIOTH ONC, 50(1), 1999, pp. 13-23

Authors: Coucke, PA Decosterd, LA Li, YX Cottin, E Chen, XG Sun, LQ Stern, S Paschoud, N Denekamp, J

Citation: Pa. Coucke et al., The ribonucleoside diphosphate reductase inhibitor (E)-2 '-deoxy(fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitro, CANCER RES, 59(20), 1999, pp. 5219-5226

Authors: Wilson, GD Paschoud, N Pavy, JJ Weber, K Weber, P Dubray, B Coucke, PA

Citation: Gd. Wilson et al., Reproducibility of measurements of potential doubling time of tumour cellsin the multicentre National Cancer Institute protocol T92-0045, BR J CANC, 79(2), 1999, pp. 323-332